Bayer Rally Takes Fresh Step on Optimism for Roundup Resolution
Summarize this article with:
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the worldAmericas+1 212 318 2000EMEA+44 20 7330 7500Asia Pacific+65 6212 1000Bayer AG Roundup brand weedkiller.A huge rally in Bayer AG shares extended this week as investors pounce on signs the weedkiller litigation that has cost the German conglomerate more than $10 billion could be largely resolved in 2026.The stock is hovering near the highest level in more than two years on prospects that the US Supreme Court could agree to hear Bayer’s challenge to a 2023 verdict by a Missouri jury. It’s up 40% in the past five weeks alone, the best performance in Europe’s benchmark Stoxx 600 Index in that period.